As of Oct 4, 2024, the Incyte stock's PE ratio is 177.61. This results from the current EPS of $0.38 and stock price of $67.49. The current PE ratio is nearly equal to the average from the previous four quarters.
The PE ratio of Incyte has averaged 234.44 over the last ten years. The current PE ratio of 177.61 is 24% below the historical average. In the past ten years, INCY's PE ratio was at its highest in the Dec 2015 quarter at 2,711.25, when the stock price was $108.45 and the EPS was $0.04. The lowest value was in the Sep 2022 quarter, when it reached 16.83 with a price of $66.64 and an EPS of $3.96.
Maximum annual increase: 207.56% in 2022
Maximum annual decrease: -93.28% in 2016
Year | PE ratio | Change |
---|---|---|
2023 | 23.52 | -55.2% |
2022 | 52.5 | 207.56% |
2021 | 17.07 | N/A |
2020 | N/A | N/A |
2019 | 41.98 | -65.67% |
2018 | 122.29 | N/A |
2017 | N/A | N/A |
2016 | 182.31 | -93.28% |
2015 | 2,711.25 | N/A |
2014 | N/A | N/A |
Currently, INCY's PE ratio is greater than its 3 and 5-year historical averages, but it is lower than the 10-year average.
INCY's PE ratio is higher than its peer stocks LLY and NVS.
Stock name | PE ratio | Market cap |
---|---|---|
NVS Novartis AG | 14.42 | $232.5B |
LGND Ligand Pharmaceuticals Inc | 42.94 | $1.91B |
AMGN Amgen Inc | 54.64 | $171.76B |
LLY ELI LILLY & Co | 108.85 | $843.18B |
INCY Incyte Corp | 177.61 | $13B |
PFE Pfizer Inc | N/A | $161.95B |
ARDX Ardelyx Inc | N/A | $1.61B |
GERN Geron Corp | N/A | $2.6B |
INCY stock has a price to earnings ratio of 177.61 as of Oct 4, 2024.
As an average over the last 3 years, INCY stock has a PE ratio of 40.11.
As an average over the last 5 years, INCY stock has a PE ratio of 40.21.
Over the last ten years, the quarterly PE ratio reached a historic high of 2,711.25 in the Dec 2015 quarter.
INCY's price to earnings ratio is currently 24% below its 10-year historical average.
INCY's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Oct 4, 2024), Incyte's stock price is $67.49. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $0.38. Therefore, Incyte's P/E ratio for today is 177.61. PE RATIO(177.61) = STOCK PRICE($67.49) / TTM EPS($0.38)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.